Format

Send to

Choose Destination
Discov Med. 2014 May;17(95):257-65.

Inflammatory disease and the human microbiome.

Author information

1
Autoimmunity Research Foundation, 3423 Hill Canyon Ave., Thousand Oaks, CA 91360, USA.
2
Weill Cornell Medical College, 1300 York Ave., New York, NY 10065, USA.

Abstract

The human body is a superorganism in which thousands of microbial genomes continually interact with the human genome. A range of physical and neurological inflammatory diseases are now associated with shifts in microbiome composition. Seemingly disparate inflammatory conditions may arise from similar disruption of microbiome homeostasis. Intracellular pathogens long associated with inflammatory disease are able to slow the innate immune response by dysregulating activity of the VDR nuclear receptor. This facilitates the ability of other species to gradually accumulate in tissue and blood, where they generate proteins and metabolites that significantly interfere with the body's metabolic processes. The microbes that contribute to this dysfunction are often inherited from family members. Immunosuppressive therapies for inflammatory disease allow pathogens driving these processes to spread with greater ease. In contrast to immunosuppression, treatments that stimulate the immune system seem to allow for reversal of this pathogen-induced genomic dysregulation.

PMID:
24882717
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Discovery Medicine
Loading ...
Support Center